Type 1 diabetes mellitus is a life-long disease that requires daily insulin injections and can lead to other serious medical complications.
The incidence of the chronic and devastating disease of type 1 diabetes has been rising at a rapidly. Approximately 10% of diabetes cases are type 1.
Patients with type 1 diabetes do not produce insulin, but the cause is still unknown. Normally, the immune system produces antibodies which protect the body from foreign invaders such as viruses, bacteria, and germs. In patients with type 1 diabetes, the immune system mistakenly attacks and destroys the healthy insulin-producing beta cells in the pancreas; Resulting in little, to no insulin available to transport sugar into cells. Therefore, sugar builds up in the blood stream and causes systemic damage.
Type 1 diabetes symptoms can appear suddenly at any age, but the majority of patients are diagnosed in early childhood or adolescence. Possible symptoms include: excessive urination, thirst, constant hunger, unexplained weight loss, changes in vision, and fatigue.
According to Researchers mesenchymal stem cells have the potential to treat many chronic diseases, including type 1 diabetes. Mesenchymal stem cells have the ability to:
In type 1 diabetes, mesenchymal stem cells can help reduce beta cell destruction and retain beta cell function.
Mesenchymal stem cells have the ability to modulate the immune system to prevent it from attacking beta cells by mistake, as well as repair already damaged beta cells. The patient’s new beta cells will function properly and control blood sugar levels.
According to preliminary results from clinical trials, mesenchymal stem cells’ action on the immune system allowed beta cells to regenerate and improve glycemic control in patients with long-term type 1 diabetes. After treatment, patients noticed continuous improvement over time.
For optimal results, the Stem Cells Transplant Institute recommends the use of human umbilical cord mesenchymal stem cells (hUC-MSCs) for the treatment of type 1 diabetes. Treatment includes:
Using stem cells to control the patient’s immune system is challenging. In some trials when beta cells were created or transplanted into a patient, their immune system would continue to target and destroy the new cells.
Scientists are researching ways to better protect the new beta cells from future destruction.
Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.
Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.
Our clinic is located in Costa Rica, which is one of the most popular medical tourism destinations for stem cell therapy. At the Stem Cells Transplant Institute, we have a skilled team of doctors and medical professionals who collect and administer stem cells to treat autism and other conditions. Every patient receives the most cost-effective and top-notch care from our dedicated team.